(Q35884889)

10 August 2017

Development of Immunopathogenesis Strategies to Treat Behçet's Disease (English)

1 reference

10 August 2017

0 references

Osman Köse

1

1 reference

10 August 2017

3 April 2012

1 reference

Pathology Research International

10 August 2017

1 reference

10 August 2017

2012

1 reference

10 August 2017

261989

1 reference

Creative Commons Attribution 3.0 Unported

10 August 2017

start time

3 April 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Th17 cells in Behçet's disease: a new immunoregulatory axis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

The use of biologic agents in the treatment of ocular manifestations of Behcet's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Infliximab for patients with neuro-Behcet's disease: case series and literature review.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Rilonacept and canakinumab

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Behçet's disease (Adamantiades-Behçet's disease).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Evaluation of current therapeutic strategies in Behçet's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Clinical experience with adalimumab in the treatment of ocular Behçet disease.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Etiopathogenesis of Behcet's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Treatment of retinal vasculitis in Behçet's disease with rituximab

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Promising new therapies for Behcet's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

New approaches in the treatment of Adamantiades-Behçet's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study

11 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

11 July 2018

https://api.crossref.org/works/10.1155%2F2012%2F261989

Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Effect of infliximab on gene expression profiling in Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet's disease: a comparative 4-week study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Safety and efficacy of etanercept in children with juvenile-onset Behcets disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Efficacy of oral tacrolimus on intestinal Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Penetration of topically applied tacrolimus into the aqueous humor in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

Mycophenolate sodium: effective treatment for therapy-refractory intestinal Behçet's disease, evaluated with enteroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Imbalance of Th17 to Th1 cells in Behçet's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

The short-term efficacy and safety treatment study of recurrent uveitis in Behcet disease with etanercept

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324914

Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease

24 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261989

HSP 60 expression in recurrent oral ulcerations of Behçet's disease

21 January 2018

1 reference

12 December 2020

Mycophenolate sodium in the treatment of mucocutaneous Behcet's diseases

1 reference

12 December 2020

Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab

1 reference

12 December 2020

Tocilizumab may be a potential addition to our weapons against neuro-Behçet’s disease

1 reference

12 December 2020

Vitamin D modulates peripheral immunity in patients with Behçet's disease

1 reference

12 December 2020

Efficacy of etanercept in the treatment of a patient with Behçet's disease

1 reference

12 December 2020

1 reference

12 December 2020

Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: presentation of four cases

1 reference

12 December 2020

Regulation of TH17 and regulatory T cells in patients with Behçet disease

1 reference

12 December 2020

IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population

1 reference

12 December 2020

Infliximab treatment for ocular and extraocular manifestations of Behçet's disease

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/261989

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

PMCID

3324914